{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:17:38Z","timestamp":1777655858355,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00277-023-05340-0","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T18:02:16Z","timestamp":1688061736000},"page":"2059-2068","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Real-life use of mTOR inhibitor-based therapy in adults with autoimmune cytopenia highlights strong efficacy in relapsing\/refractory multi-lineage autoimmune cytopenia"],"prefix":"10.1007","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3443-9201","authenticated-orcid":false,"given":"Boris","family":"Sorin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jehane","family":"Fadlallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaux","family":"Garzaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Vigneron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9mi","family":"Bertinchamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Boutboul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Oksenhendler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Fieschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Malphettes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel","family":"Galicier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"5340_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-2141.2008.07216.x","volume":"142","author":"K Sawada","year":"2008","unstructured":"Sawada K, Fujishima N, Hirokawa M (2008) Acquired pure red cell aplasia: updated review of treatment. Br J Haematol 142:505\u2013514. https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07216.x","journal-title":"Br J Haematol"},{"key":"5340_CR2","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1182\/blood-2016-05-717140","volume":"128","author":"RT Means","year":"2016","unstructured":"Means RT (2016) Pure red cell aplasia. Blood 128:2504\u20132509. https:\/\/doi.org\/10.1182\/blood-2016-05-717140","journal-title":"Blood"},{"key":"5340_CR3","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113:2386\u20132393. https:\/\/doi.org\/10.1182\/blood-2008-07-162503","journal-title":"Blood"},{"key":"5340_CR4","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","volume":"3","author":"D Provan","year":"2019","unstructured":"Provan D, Arnold DM, Bussel JB et al (2019) Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 3:3780\u20133817. https:\/\/doi.org\/10.1182\/bloodadvances.2019000812","journal-title":"Blood Adv"},{"key":"5340_CR5","doi-asserted-by":"publisher","first-page":"100648","DOI":"10.1016\/j.blre.2019.100648","volume":"41","author":"U J\u00e4ger","year":"2020","unstructured":"J\u00e4ger U, Barcellini W, Broome CM et al (2020) Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Rev 41:100648. https:\/\/doi.org\/10.1016\/j.blre.2019.100648","journal-title":"Blood Rev"},{"key":"5340_CR6","doi-asserted-by":"publisher","first-page":"e814","DOI":"10.1097\/HS9.0000000000000814","volume":"7","author":"F Fioredda","year":"2023","unstructured":"Fioredda F, Dufour C, H\u00f6glund P et al (2023) Autoimmune neutropenias: update on clinical and biological features in children and adults. HemaSphere 7:e814. https:\/\/doi.org\/10.1097\/HS9.0000000000000814","journal-title":"HemaSphere"},{"key":"5340_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/archinte.1951.03810010058005","volume":"87","author":"RS Evans","year":"1951","unstructured":"Evans RS, Takahashi K, Duane RT et al (1951) Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology. AMA Arch Intern Med 87:48\u201365. https:\/\/doi.org\/10.1001\/archinte.1951.03810010058005","journal-title":"AMA Arch Intern Med"},{"key":"5340_CR8","doi-asserted-by":"publisher","first-page":"869033","DOI":"10.3389\/fimmu.2022.869033","volume":"13","author":"M Miano","year":"2022","unstructured":"Miano M, Guardo D, Grossi A et al (2022) Underlying inborn errors of immunity in patients with Evans syndrome and multilineage cytopenias: a single-centre analysis. Front Immunol 13:869033. https:\/\/doi.org\/10.3389\/fimmu.2022.869033","journal-title":"Front Immunol"},{"key":"5340_CR9","doi-asserted-by":"publisher","unstructured":"Kumar D, Nguyen TH, Bennett CM et al (2022) mTOR inhibition attenuates cTfh cell dysregulation and chronic T cell activation in multi-lineage immune cytopenias. Blood blood.2022015966. https:\/\/doi.org\/10.1182\/blood.2022015966","DOI":"10.1182\/blood.2022015966"},{"key":"5340_CR10","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3390\/cancers13071532","volume":"13","author":"W Barcellini","year":"2021","unstructured":"Barcellini W, Giannotta JA, Fattizzo B (2021) Autoimmune complications in hematologic neoplasms. Cancers 13:1532. https:\/\/doi.org\/10.3390\/cancers13071532","journal-title":"Cancers"},{"key":"5340_CR11","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/ajh.23785","volume":"89","author":"C Visco","year":"2014","unstructured":"Visco C, Barcellini W, Maura F et al (2014) Autoimmune cytopenias in chronic lymphocytic leukemia. Am J Hematol 89:1055\u20131062. https:\/\/doi.org\/10.1002\/ajh.23785","journal-title":"Am J Hematol"},{"key":"5340_CR12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1053\/j.seminoncol.2006.01.011","volume":"33","author":"T Hamblin","year":"2006","unstructured":"Hamblin T (2006) Autoimmune complications of chronic lymphocytic leukemia. Semin Oncol 33:230\u2013239. https:\/\/doi.org\/10.1053\/j.seminoncol.2006.01.011","journal-title":"Semin Oncol"},{"key":"5340_CR13","doi-asserted-by":"publisher","first-page":"e2818","DOI":"10.1097\/MD.0000000000002818","volume":"95","author":"J-H Jung","year":"2016","unstructured":"Jung J-H, Soh M-S, Ahn Y-H et al (2016) Thrombocytopenia in systemic lupus erythematosus: clinical manifestations, treatment, and prognosis in 230 patients. Medicine (Baltimore) 95:e2818. https:\/\/doi.org\/10.1097\/MD.0000000000002818","journal-title":"Medicine (Baltimore)"},{"key":"5340_CR14","doi-asserted-by":"publisher","first-page":"e19015","DOI":"10.1097\/MD.0000000000019015","volume":"99","author":"J-C Zhou","year":"2020","unstructured":"Zhou J-C, Wu M-Q, Peng Z-M et al (2020) Clinical analysis of 20 patients with non-Hodgkin lymphoma and autoimmune hemolytic anemia: a retrospective study. Medicine (Baltimore) 99:e19015. https:\/\/doi.org\/10.1097\/MD.0000000000019015","journal-title":"Medicine (Baltimore)"},{"key":"5340_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/ejh.13239","volume":"103","author":"E Crickx","year":"2019","unstructured":"Crickx E, Poullot E, Moulis G et al (2019) Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T-cell lymphoma. Eur J Haematol 103:35\u201342. https:\/\/doi.org\/10.1111\/ejh.13239","journal-title":"Eur J Haematol"},{"key":"5340_CR16","doi-asserted-by":"publisher","first-page":"5468","DOI":"10.1182\/bloodadvances.2021005610","volume":"5","author":"B Fattizzo","year":"2021","unstructured":"Fattizzo B, Michel M, Giannotta JA et al (2021) Evans syndrome in adults: an observational multicenter study. Blood Adv 5:5468\u20135478. https:\/\/doi.org\/10.1182\/bloodadvances.2021005610","journal-title":"Blood Adv"},{"key":"5340_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMoa1204166","volume":"367","author":"S Euvrard","year":"2012","unstructured":"Euvrard S, Morelon E, Rostaing L et al (2012) Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med 367:329\u2013339. https:\/\/doi.org\/10.1056\/NEJMoa1204166","journal-title":"N Engl J Med"},{"key":"5340_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/TP.0b013e3181e11798","volume":"90","author":"M Guba","year":"2010","unstructured":"Guba M, Pratschke J, Hugo C et al (2010) Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trial. Transplantation 90:175\u2013183. https:\/\/doi.org\/10.1097\/TP.0b013e3181e11798","journal-title":"Transplantation"},{"key":"5340_CR19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/bjh.13010","volume":"167","author":"M Miano","year":"2014","unstructured":"Miano M, Calvillo M, Palmisani E et al (2014) Sirolimus for the treatment of multi-resistant autoimmune haemolytic anaemia in children. Br J Haematol 167:571\u2013574. https:\/\/doi.org\/10.1111\/bjh.13010","journal-title":"Br J Haematol"},{"key":"5340_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/bjh.13533","volume":"171","author":"M Miano","year":"2015","unstructured":"Miano M, Scalzone M, Perri K et al (2015) Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience. Br J Haematol 171:247\u2013253. https:\/\/doi.org\/10.1111\/bjh.13533","journal-title":"Br J Haematol"},{"key":"5340_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1182\/blood-2015-07-657981","volume":"127","author":"KL Bride","year":"2016","unstructured":"Bride KL, Vincent T, Smith-Whitley K et al (2016) Sirolimus is effective in relapsed\/refractory autoimmune cytopenias: results of a prospective multi-institutional trial. Blood 127:17\u201328. https:\/\/doi.org\/10.1182\/blood-2015-07-657981","journal-title":"Blood"},{"key":"5340_CR22","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/MPH.0000000000000818","volume":"39","author":"S Jasinski","year":"2017","unstructured":"Jasinski S, Weinblatt ME, Glasser CL (2017) Sirolimus as an effective agent in the treatment of immune thrombocytopenia (ITP) and Evans syndrome (ES): a single institution\u2019s experience. J Pediatr Hematol Oncol 39:420\u2013424. https:\/\/doi.org\/10.1097\/MPH.0000000000000818","journal-title":"J Pediatr Hematol Oncol"},{"key":"5340_CR23","doi-asserted-by":"publisher","first-page":"E175","DOI":"10.1002\/ajh.25119","volume":"93","author":"M Miano","year":"2018","unstructured":"Miano M, Rotulo GA, Palmisani E et al (2018) Sirolimus as a rescue therapy in children with immune thrombocytopenia refractory to mycophenolate mofetil. Am J Hematol 93:E175\u2013E177. https:\/\/doi.org\/10.1002\/ajh.25119","journal-title":"Am J Hematol"},{"key":"5340_CR24","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1007\/s00277-018-3431-5","volume":"97","author":"Z Long","year":"2018","unstructured":"Long Z, Yu F, Du Y et al (2018) Successful treatment of refractory\/relapsed acquired pure red cell aplasia with sirolimus. Ann Hematol 97:2047\u20132054. https:\/\/doi.org\/10.1007\/s00277-018-3431-5","journal-title":"Ann Hematol"},{"key":"5340_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fmed.2020.00110","volume":"7","author":"Y Feng","year":"2020","unstructured":"Feng Y, Xiao Y, Yan H et al (2020) Sirolimus as rescue therapy for refractory\/relapsed immune thrombocytopenia: results of a single-center, prospective single-arm study. Front Med 7:110. https:\/\/doi.org\/10.3389\/fmed.2020.00110","journal-title":"Front Med"},{"key":"5340_CR26","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00277-020-03946-2","volume":"99","author":"Z Chen","year":"2020","unstructured":"Chen Z, Liu X, Chen M et al (2020) Successful sirolimus treatment of patients with pure red cell aplasia complicated with renal insufficiency. Ann Hematol 99:737\u2013741. https:\/\/doi.org\/10.1007\/s00277-020-03946-2","journal-title":"Ann Hematol"},{"key":"5340_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.exphem.2020.08.001","volume":"89","author":"H Li","year":"2020","unstructured":"Li H, Ji J, Du Y et al (2020) Sirolimus is effective for primary relapsed\/refractory autoimmune cytopenia: a multicenter study. Exp Hematol 89:87\u201395. https:\/\/doi.org\/10.1016\/j.exphem.2020.08.001","journal-title":"Exp Hematol"},{"key":"5340_CR28","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1093\/rheumatology\/keaa645","volume":"60","author":"C Wu","year":"2021","unstructured":"Wu C, Wang Q, Xu D et al (2021) Sirolimus for patients with connective tissue disease-related refractory thrombocytopenia: a single-arm, open-label clinical trial. Rheumatol Oxf Engl 60:2629\u20132634. https:\/\/doi.org\/10.1093\/rheumatology\/keaa645","journal-title":"Rheumatol Oxf Engl"},{"key":"5340_CR29","doi-asserted-by":"publisher","first-page":"857424","DOI":"10.3389\/fimmu.2022.857424","volume":"13","author":"W Xie","year":"2022","unstructured":"Xie W, Ji L, Zhang Z (2022) Sirolimus monotherapy for thrombocytopenia in primary antiphospholipid syndrome: a pilot study from a tertiary referral center. Front Immunol 13:857424. https:\/\/doi.org\/10.3389\/fimmu.2022.857424","journal-title":"Front Immunol"},{"key":"5340_CR30","doi-asserted-by":"publisher","unstructured":"Y Y, Z T, Y H et al (2023) Sirolimus versus cyclosporine A in patients with primary acquired pure red cell aplasia: a prospective cohort study. Blood Cancer J 13. https:\/\/doi.org\/10.1038\/s41408-023-00845-3","DOI":"10.1038\/s41408-023-00845-3"},{"key":"5340_CR31","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1086\/606059","volume":"49","author":"M Malphettes","year":"2009","unstructured":"Malphettes M, G\u00e9rard L, Carmagnat M et al (2009) Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis Off Publ Infect Dis Soc Am 49:1329\u20131338. https:\/\/doi.org\/10.1086\/606059","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"5340_CR32","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1182\/blood-2010-04-280347","volume":"116","author":"JB Oliveira","year":"2010","unstructured":"Oliveira JB, Bleesing JJ, Dianzani U et al (2010) Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood 116:e35-40. https:\/\/doi.org\/10.1182\/blood-2010-04-280347","journal-title":"Blood"},{"key":"5340_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s10875-012-9778-9","volume":"33","author":"J-N Boursiquot","year":"2013","unstructured":"Boursiquot J-N, G\u00e9rard L, Malphettes M et al (2013) Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients. J Clin Immunol 33:84\u201395. https:\/\/doi.org\/10.1007\/s10875-012-9778-9","journal-title":"J Clin Immunol"},{"key":"5340_CR34","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jaci.2021.04.039","volume":"149","author":"D Egg","year":"2022","unstructured":"Egg D, Rump IC, Mitsuiki N et al (2022) Therapeutic options for CTLA-4 insufficiency. J Allergy Clin Immunol 149:736\u2013746. https:\/\/doi.org\/10.1016\/j.jaci.2021.04.039","journal-title":"J Allergy Clin Immunol"},{"key":"5340_CR35","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.jaci.2019.12.896","volume":"145","author":"VK Tesch","year":"2020","unstructured":"Tesch VK, Abolhassani H, Shadur B et al (2020) Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score. J Allergy Clin Immunol 145:1452\u20131463. https:\/\/doi.org\/10.1016\/j.jaci.2019.12.896","journal-title":"J Allergy Clin Immunol"},{"key":"5340_CR36","doi-asserted-by":"publisher","first-page":"548085","DOI":"10.1155\/2013\/548085","volume":"2013","author":"J Li","year":"2013","unstructured":"Li J, Wang Z, Dai L et al (2013) Effects of rapamycin combined with low dose prednisone in patients with chronic immune thrombocytopenia. Clin Dev Immunol 2013:548085. https:\/\/doi.org\/10.1155\/2013\/548085","journal-title":"Clin Dev Immunol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05340-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05340-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05340-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T07:07:51Z","timestamp":1689232071000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05340-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["5340"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05340-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"assertion":[{"value":"1 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In conformity with the principles of the Helsinki declaration and according to the French Jard\u00e9 law, written consent of the patients is not required in France for retrospective and observational non-interventional study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval statement and patient consent statement"}},{"value":"The authors declare they have no competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}